Critical Access Hospital (CAH) Conditions of Participation 2023 – Part 2

 More

Critical Access Hospital (CAH) Conditions of Participation 2023 – Part 2

Centers for Medicare and Medicaid, Conditions of Participation

About the Series:

The Critical Access Manual has seen multiple changes over the last few years. From all new tag numbers and new requirements for QAPI, to Infection Prevention and Control, and the Antibiotic Stewardship Program, this five-part series will cover the CAN manual and more.  Attendees will learn details about the Conditions of Participation, and what to do and expect when a surveyor arrives at your facility.  This complete series will further help a Critical Access Hospital comply with problem areas including nursing care plans, necessary policies and procedures, medication management, and emergency preparedness. 

Who should attend:

CEOs, COOs, CFOs, Nurse Executives (CNO), Accreditation and Regulation Director, Nurse Managers, Pharmacists, Pharmacist Compliance Officers, Health information management, Nurses, Nurse Educators, Nursing Supervisors, Quality Managers, Risk Managers, Healthcare Attorneys, Health Information Management Personnel, Social Workers, Patient safety officer, Infection preventionist, Radiology director, Emergency Department Directors, Outpatient Director, Medication Team, Ethicist, Director of Rehab: OT, PT, speech pathology, and audiology, CRNA, Anesthesia providers, Radiology staff, QAPI staff, Policy and Procedure Committee, Dietician, Activities Director of swing bed patients, and Infection Control Committee Members.

Learning Objectives:

  • Explain the responsibilities of the pharmacists that include developing, supervising, and coordinating activities of the pharmacy.
  • Describe the requirements for CAH to monitor and inspect to ensure that outdated drugs are not available for patient use.
  • Recall the requirements for security and storage of medications, medication carts and anesthesia carts.
  • Discuss the requirement to have a list of do not use abbreviations and a review of sound alike/look alike drugs.

Faculty

Nash Healthcare Consulting